Theranexus SA (3VG) Stock Statistics & Valuation Metrics

Theranexus SA has a market cap or net worth of €45.62M. The enterprise value is €33.30M.

Theranexus SA has 14,472,778 shares outstanding. The number of shares has decreased by -2.65% in one year.

Theranexus SA’s return on equity (ROE) is -1.51 and return on invested capital (ROIC) is -120.30%.

The current PE Ratio of Theranexus SA is ―. Theranexus SA’s PEG ratio is -2.04.

In the last 12 months, Theranexus SA had revenue of 0.00 and earned -3.00M in profits. Earnings per share was -0.22.

In the last 12 months, operating cash flow was 9.07M and capital expenditures -207.41K, giving a free cash flow of 8.86M billion.

Theranexus SA pays an annual dividend of ―, resulting in a dividend yield of ―

Theranexus SA upcoming earnings date is May 4, 2027, Before Open (Not Confirmed).

Theranexus SA as a current ratio of 1.55, with Debt / Equity ratio of 122.52%

In the past 12 months, Theranexus SA has paid -998.03K in taxes.

Theranexus SA EV to EBITDA ratio is -3.12, with an EV/FCF ratio of -33.61.

Theranexus SA has €17.45M in cash and marketable securities with €2.59M in debt, giving a net cash position of €14.86M billion.

Gross margin is -1.87%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Theranexus SA is ―, which is 11.43% higher than the current price. The consensus rating is ―